Media Encompassing Truth, Integrity, and Objective Reporting

Fatal Blood Clotting – Global Population at Risk

AstraZeneca’s Vaxzevria Covid vaccine has been pulled from distribution worldwide, following revelations of fatal blood clots associated with its use. This decision comes a year after the vaccine was halted in Australia.

The UK pharmaceutical giant AstraZeneca has acknowledged a rare but potentially deadly side effect linked to its Covid-19 vaccine, which has been widely used around the globe. The withdrawal of the vaccine was announced globally on Tuesday, according to reports from the UK’s Telegraph.

The move follows the decision by Australia’s Therapeutic Goods Authority to discontinue the use of the AstraZeneca vaccine in April 2023.

AstraZeneca’s admission came after it was revealed through court documents in a UK class action lawsuit that the vaccine, marketed as Vaxzevria, could lead to fatal blood clots and low platelet counts. The application for withdrawal was submitted on March 5 and became effective on May 7.

Although the AstraZeneca vaccine had been provisionally approved for use in Australia for individuals aged 18 and over, it faced competition from Pfizer and Moderna vaccines, which were recommended over AstraZeneca’s offering. In June 2021, the Australian Technical Advisory Group on Immunisation advised against the use of Vaxzevria for individuals over the age of 60.

Former Prime Minister Scott Morrison had previously encouraged Australians over 60 to opt for the AstraZeneca vaccine instead of waiting for other vaccine options to become available, emphasizing the importance of vaccination in saving lives and returning to normalcy.






Leave a Reply

Your email address will not be published. Required fields are marked *